AntiInfectiveMeds
Since 2010
| Quantity | Price per tube | You save | Total price | |
|---|---|---|---|---|
| 7 | C$14.80 | - | C$103.60 | |
| 8 | C$14.70 | C$0.80 | C$117.60 | |
| 9 | C$14.47 | C$3.00 | C$130.20 | |
| 10 | C$14.28 | C$5.20 | C$142.80 | |
| 12 | C$14.00 | C$9.60 | C$168.00 |
Your order is carefully packed and ships within 24 hours. Here is what a typical package looks like.
Sized like a regular personal letter (approximately 24x11x0.7 cm), with no indication of what is inside.
| Shipping Method | Estimated delivery |
|---|---|
| Express Free for orders over C$420.00 | Estimated delivery to Canada: 4-7 days |
| Standard Free for orders over C$280.00 | Estimated delivery to Canada: 14-21 days |
| Country | Brand Names |
|---|---|
| Canada | Betaderm Diprosone |
Betamethasone is a synthetic glucocorticosteroid for external use. It has high glucocorticosteroid activity and only minimal mineralocorticoid effect.
What does Betnovate cream do? When betamethasone is used topically, the cream may be absorbed to a lesser extent by normal, uninjured skin; systemic absorption of corticosteroids is expected only under unfavourable conditions (e.g., skin inflammation, prolonged treatment, or use under occlusive dressings).
Because of their anti-inflammatory, antipruritic, and vasoconstrictive effects, topical glucocorticosteroids such as betamethasone should preferentially be used to treat corticosteroid-sensitive dermatoses.
In Canada, betamethasone and its formulations are approved by Health Canada, the federal department responsible for national health policy. Health Canada evaluates and monitors the safety, efficacy, and quality of therapeutic products, including prescription medications. The medication's approval by Health Canada is based on comprehensive evaluations of its safety and efficacy, which include clinical data from various studies. These studies assess the drug's effectiveness in treating inflammatory skin conditions and monitor potential side effects. Healthcare professionals in Canada rely on this data to inform prescribing practices.
Active pharmaceutical ingredients:
Ingredients: caprylic/capric triglycerides, propylene glycol, Vaseline, emulsifier, purified water.
In Canada, betamethasone is marketed under several brand names, including:
Additionally, betamethasone dipropionate is available under brand names such as Diprosone and Taro-Sone, used for treating various skin conditions.
For reduction of inflammatory manifestations of dermatoses sensitive to GCS therapy, such as all types of eczema and dermatitis (including atopic eczema and photodermatitis), lichen planus, nodular prurigo, discoid lupus erythematosus, lipoid necrobiosis, pretibial myxedema, and erythroderma. It may also be effective in the treatment of psoriasis of the scalp and plaque psoriasis of the upper and lower extremities, except for widespread plaque psoriasis.
Betamethasone valerate is classified as a prescription-only medication in Canada. This means it requires a valid prescription from a licensed healthcare provider for dispensing.
Betamethasone is contraindicated in patients with allergic reactions to any of the drug components.
Betamethasone is contraindicated in the following cases:
The use of betamethasone cream under occlusive dressings (plaster, etc.) is not recommended. Prolonged treatment and/or use over a large area of the skin should be avoided because the active ingredient may be absorbed.
Betamethasone has a pronounced dose-dependent effect on the metabolism of carbohydrates, proteins, and fats. It has a catabolic effect in lymphoid and connective tissue, muscles, adipose tissue, skin, and bone tissue. Osteoporosis and Itzenko-Cushing's syndrome are the main factors limiting long-term GCS therapy.
If you use betamethasone regularly and want to stop taking it, talk to your doctor first, as your condition may worsen if you stop suddenly. If you have any further questions, contact your doctor or pharmacist.
Use Betnovate cream only according to the indication, route of administration, and dose given in the instructions for use.
In Canada, betamethasone is available in multiple forms and strengths to cater to different dermatological needs:
These formulations are designed to treat various skin conditions, with the choice of form and strength depending on the specific condition and its severity.
Method of administration
Eczema is an inflammatory skin disease with a variety of primary and secondary symptoms, including polymorphic rashes. Treatment of this dermatological pathology is often long-term and aims to eliminate all irritating factors. It should be carried out as part of a comprehensive approach, which includes local therapy and desensitization of the body and, if necessary, correction of systemic diseases and autonomic disorders.
Betamethasone cream for eczema has an exfoliating, antipruritic, and soothing effect. It contributes to the restoration of damaged skin and suppresses the action of pathogenic agents that have provoked the development of psoriasis or eczema. A positive effect is also achieved thanks to the soothing, moisturizing, and disinfecting properties of these medicines.
What is the difference between eczema and atopic dermatitis? Modern science often groups these two conditions together because they share many symptoms (redness of the skin, itching, swelling, rash), are triggered by similar allergens (food, household, etc.), and are treated with similar medications.
The main method of treatment of dermatitis and eczema is topical therapy with glucocorticosteroids. Some people are prejudiced against hormones and are afraid to use them even topically; however, there is no reason for such fears.
If you use GCS externally in the right way (no more than 2 times a day, gently rubbing in a thin layer in an amount no greater than necessary to cover the affected area, until the effect is achieved, and for no longer than 4 weeks), there is no reason to fear adverse reactions. This is because topical agents act at the site of application without having a systemic effect on the entire body, as is the case with oral GCS.
Allergic contact dermatitis, unlike simple contact dermatitis, does not develop from the first contact with an irritant or the first exposure. It may take up to several weeks after initial contact for the allergic reaction (sensitization) to develop. Then dermatitis develops on repeated contact. The inflammatory skin reaction is not consistent with the intensity of the irritant, which will not cause any changes in non-allergic people. The area of change on the skin may extend beyond the contact.
Simple dermatitis occurs acutely or chronically. Acute dermatitis is characterized by pronounced inflammation accompanied by itching, burning, pain, and sometimes by the formation of blisters and areas of necrosis that leave scars. If dermatitis occurs, it is better to see a doctor rather than self-treat. In the treatment of simple contact dermatitis, the main thing is to stop the irritant. Often patients, understanding the cause of the disease, cope with it on their own. However, there are cases (for example, severe chemical and thermal burns, frostbite) when a doctor's intervention is necessary.
Betamethasone cream meets the highest requirements for drugs used in dermatological practice for external application. It has minimal resorptive effect and practically no systemic effect. This is a major advantage of modern GCS-containing topical preparations over first-generation steroid ointments.
Modern pharmacology has made a lot of effort to ensure that the patient has a choice of highly effective psoriasis medications that help against exacerbations and complications. Since the course of the disease is always individual and manifests itself differently in each patient, the treatment of the disease also depends on the individual case. The therapy of a multifactorial disease is always carried out in a comprehensive manner. The complex pathogenetic mechanism of psoriasis development leads to morphofunctional changes in the whole organism; that is why different pharmacological groups are used for treatment.
Betamethasone is an external form, which is the main one in the treatment of this disease. This is justified by the fact that the skin is affected first. When a special therapeutic cream is applied to the skin, absorption occurs immediately, providing therapeutic benefit. In this case, healthy areas of the skin are practically unaffected, which helps prevent penetration of active elements into the systemic bloodstream. This is important since many psoriasis medications have certain side effects.
If the patient has psoriatic plaques on the elbows or knees, the doctor may recommend applying the cream under sealed occlusive dressings. However, this is usually recommended when applying the cream at night to enhance the effect. You should return to the normal application mode after a short period.
The frequency and severity of betamethasone side effects depend on the duration of betamethasone dipropionate use and the size of the dose used. High doses or prolonged use of GCS may cause marked mineralocorticoid and glucocorticoid effects that are considered side effects.
In Canada, users of betamethasone have reported side effects such as burning, itching, and irritation at the application site. Some individuals may experience dryness or redness of the skin. Prolonged use can lead to skin thinning or discolouration. It's essential to monitor for any adverse reactions and consult a healthcare provider if symptoms persist or worsen.
External betamethasone cream use may result in:
During long-term treatment it is necessary to carefully monitor growth and development in children, periodically perform ophthalmologic examinations (to detect glaucoma, cataracts, etc.), regularly monitor hypothalamic-pituitary-adrenal axis function, blood and urine glucose content (especially in diabetic patients), serum electrolytes, and occult blood in feces. In the case of systemic use, EEG monitoring is recommended.
Common side effects: Burning sensation, pain, irritation, or itching in the areas where the ointment is applied.
Serious side effects may occur with prolonged use: skin maceration, secondary infection, skin atrophy, local hirsutism, telangiectasia, sweating, purpura.
Allergies are genetic diseases, i.e., predisposition to develop allergies is inherited. For example, if one parent suffers from allergies, the likelihood of the child developing allergic diseases is 25-40%. If both parents suffer from allergies, the likelihood increases to 50-75%. It also depends on several other factors that contribute to the emergence of allergies in children, including the level of antigenic load (living conditions, improper diet) and the environment.
When used systemically, the therapeutic activity of betamethasone is due to its anti-inflammatory, anti-allergic, immunosuppressive, and antiproliferative effects. When used topically, the therapeutic activity of betamethasone is due to anti-inflammatory, anti-allergic, and anti-exudative effects (due to the vasoconstrictor effect).
Excessive or prolonged use of topical corticosteroids may cause suppression of pituitary-adrenal function, resulting in secondary adrenal insufficiency.
Although acute overdose is unlikely, chronic overdose may occur with excessive or prolonged use and may lead to hypercorticism: hyperglycemia, glucosuria, reversible depression of adrenal function, Icenko-Cushing's syndrome.
Gradual withdrawal of the drug and, if necessary, symptomatic treatment is recommended.
Prolonged external application on the face is not recommended; rosacea, perioral dermatitis, and acne may develop. The course of treatment should not exceed 5 days.
During prolonged treatment, if the drug is applied to a large surface of the body, as well as in the axillae and groin folds, when using occlusive dressings, diapers, systemic absorption of glucocorticosteroids is possible.
Consult your doctor or pharmacist before using betamethasone:
If in any doubt about your condition, ask your doctor or pharmacist before using betamethasone.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning a pregnancy, consult your doctor or pharmacist before using this medicine.
Due to the presence of white soft paraffin and mineral oil, applying betamethasone cream in the anogenital area may damage latex condoms and reduce their effectiveness during treatment.
Store in the original container at a temperature not exceeding 25°C. Do not freeze. Keep out of the reach of children.
I am ordering from Winnipeg in winter. Can cold weather ruin Betnovate cream during shipping?
Betnovate is shipped in its medicine packaging inside a protective parcel. After delivery, bring it indoors and store it as directed on the package. If the package looks damaged, contact support before using it.
My prescription says Betaderm, but I found Betnovate here. Are they the same order?
Betaderm and Betnovate are both brand names associated with betamethasone products. If your prescription allows betamethasone cream, Betnovate may fit; if it names a specific brand, form, or strength, follow that wording.
I only want one Betnovate tube for a first order. Do you sell 1 tube?
No. In our store, Betnovate starts from 7 tubes. If you want to try one tube first, you can buy it at a local pharmacy and then place a larger order with us later.
| Active ingredient | Betamethasone valerate |
|---|---|
| Drug class | Potent topical corticosteroid |
| Dosage form | Topical cream |
| Available package | 20 g cream tubes |
| Route | Topical |
| ATC code | D07AC01 |
This product has 106 ratings, but only 2 written reviews so far. Share your experience and help other customers.
I'll order again.
Betnovate was packed securely.
